Table of contents
Volume 90, Issue 8
Published online 13 April 2004 (1469-1689)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor
Minireview
Targeted radiotherapy of brain tumours FREE
M R Zalutsky
Br J Cancer 90: 1469-1473; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601771
Clinical
Information needs of Asian and White British cancer patients and their families in Leicestershire: a cross-sectional survey FREE
D Muthu Kumar, R P Symonds, S Sundar, K Ibrahim, B S P Savelyich and E Miller
Br J Cancer 90: 1474-1478; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601774
Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas FREE
R Robertson, N C Campbell, S Smith, P T Donnan, F Sullivan, R Duffy, L D Ritchie, D Millar, J Cassidy and A Munro
Br J Cancer 90: 1479-1485; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601753
Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines FREE
L Wyld, D K Garg, I D Kumar, H Brown and M W R Reed
Br J Cancer 90: 1486-1491; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601742
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up FREE
R I Olivier, M van Beurden, M A C Lubsen, M A Rookus, T M Mooij, M J van de Vijver and L J van't Veer
Br J Cancer 90: 1492-1497; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601692
Management of hepatic epithelioid haemangio-endothelioma in children: what option? FREE
K Sharif, M English, P Ramani, D Alberti, J-B Otte, P McKiernan, S Gosseye, M Jenney and J de Ville de Goyet
Br J Cancer 90: 1498-1501; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601720
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study FREE
J Feliu, A Salud, P Escudero, L López-Gómez, C Pericay, C Castañón, M R López de Tejada, J M Rodríguez-García, M P Martínez, M Sanz Martín, J J Sánchez and M González Barón on behalf of the Oncopaz Cooperative Group and Associated Hospitals
Br J Cancer 90: 1502-1507; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601713
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor FREE
A Sparreboom, D F S Kehrer, R H J Mathijssen, R Xie, M J A de Jonge, P de Bruijn, A S T Planting, F A L M Eskens, C Verheij, G de Heus, A Klaren, S Zhang, T Verhaeghe, P A Palmer and J Verweij
Br J Cancer 90: 1508-1515; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601732
A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer FREE
D C Doval, J S Sekhon, S K Gupta, J Fuloria, V K Shukla, S Gupta and B S Awasthy
Br J Cancer 90: 1516-1520; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601736
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) FREE
S Cascinu, M Scartozzi, R Labianca, V Catalano, R R Silva, S Barni, A Zaniboni, A D'Angelo, S Salvagni, G Martignoni, G D Beretta, F Graziano, R Berardi and V Franciosi
Br J Cancer 90: 1521-1525; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601752
Outcome of patients with HIV-related germ cell tumours: a case–control study FREE
T Powles, M Bower, J Shamash, J Stebbing, J Ong, G Daugaard, A De Ruiter, M Johnson, M Fisher, J Anderson, M Nelson, B Gazzard and T Oliver
Br J Cancer 90: 1526-1530; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601762
Molecular and Cellular Pathology
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers FREE
B Weigelt, P Verduijn, A J Bosma, E J Rutgers, H L Peterse and L J van't Veer
Br J Cancer 90: 1531-1537; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601659
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast FREE
R R Millis, S E Pinder, K Ryder, R Howitt and S R Lakhani
Br J Cancer 90: 1538-1542; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601704
Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients FREE
J A van der Hage, L J C M van den Broek, C Legrand, P C Clahsen, C J A Bosch, E C Robanus-Maandag, C J H van de Velde and M J van de Vijver
Br J Cancer 90: 1543-1550; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601741
200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up FREE
R Reitsamer, F Peintinger, E Prokop, L Rettenbacher and C Menzel
Br J Cancer 90: 1551-1554; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601765
The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients FREE
D Masuya, C Huang, D Liu, T Nakashima, K Kameyama, R Haba, M Ueno and H Yokomise
Br J Cancer 90: 1555-1562; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601718
Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients FREE
H Shomura, S Shichijo, S Matsueda, T Kawakami, Y Sato, S Todo and K Itoh
Br J Cancer 90: 1563-1571; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601728
A population-based study of immunohistochemical detection of p53 alteration in bladder cancer FREE
K T Kelsey, T Hirao, A Schned, S Hirao, T Devi-Ashok, H H Nelson, A Andrew and M R Karagas
Br J Cancer 90: 1572-1576; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601748
Stromal–epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression FREE
L A Dawson, N J Maitland, A J Turner and B A Usmani
Br J Cancer 90: 1577-1582; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601717
A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens FREE
I S Scott, T M Heath, L S Morris, S M Rushbrook, K Bird, S L Vowler, M J Arends and N Coleman
Br J Cancer 90: 1583-1590; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601660
Genetics and Genomics
Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas FREE
S Jones, S Lambert, G T Williams, J M Best, J R Sampson and J P Cheadle
Br J Cancer 90: 1591-1593; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601747
Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer FREE
M M Sasiadek, A Stembalska-Kozlowska, R Smigiel, D Ramsey, T Kayademir and N Blin
Br J Cancer 90: 1594-1599; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601679
High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas FREE
T Takano, A Miyauchi, H Yoshida, K Kuma and N Amino
Br J Cancer 90: 1600-1605; advance online publication, March 9, 2004; doi:10.1038/sj.bjc.6601702
Methylation analysis of the glypican 3 gene in embryonal tumours FREE
G Boily, Z Saikali and D Sinnett
Br J Cancer 90: 1606-1611; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601716
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses FREE
J Blancato, B Singh, A Liu, D J Liao and R B Dickson
Br J Cancer 90: 1612-1619; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601703
Experimental Therapeutics
Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer FREE
W Liu, Y D Jung, S A Ahmad, M F McCarty, O Stoeltzing, N Reinmuth, F Fan and L M Ellis
Br J Cancer 90: 1620-1626; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601723
Improved biological activity of a mutant endostatin containing a single amino-acid substitution FREE
Y Yokoyama and S Ramakrishnan
Br J Cancer 90: 1627-1635; advance online publication, March 30, 2004; doi:10.1038/sj.bjc.6601745
Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells FREE
R C-F Chan, X-W Pang, Y-D Wang, W-F Chen and Y Xie
Br J Cancer 90: 1636-1643; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601706
-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells FREE
M Tomasetti, M R Rippo, R Alleva, S Moretti, L Andera, J Neuzil and A Procopio
Br J Cancer 90: 1644-1653; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601707
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats FREE
M Verschraagen, E Boven, E Torun, C A M Erkelens, F H Hausheer and W J F van der Vijgh
Br J Cancer 90: 1654-1659; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601719
Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies FREE
C Perotti, H Fukuda, G DiVenosa, A J MacRobert, A Batlle and A Casas
Br J Cancer 90: 1660-1665; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601722
A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents FREE
A R Parker, C P Leonard, L Hua, R O Francis, S Dhara, A Maitra and J R Eshleman
Br J Cancer 90: 1666-1671; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601740
Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice FREE
N Sawada, K Kataoka, K Kondo, H Arimochi, H Fujino, Y Takahashi, T Miyoshi, T Kuwahara, Y Monden and Y Ohnishi
Br J Cancer 90: 1672-1678; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601746
Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2 FREE
J E Nutt, H P Lazarowicz, J K Mellon and J Lunec
Br J Cancer 90: 1679-1685; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601768
Letters to the Editor
Overdiagnosis of breast cancer in Denmark FREE
P-H Zahl
Br J Cancer 90: 1686; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601738
Reply: Overdiagnosis of breast cancer in Denmark FREE
A H Olsen, A Jensen, S H Njor, E Villadsen, W Schwartz, I Vejborg and E Lynge
Br J Cancer 90: 1687; advance online publication, March 16, 2004; doi:10.1038/sj.bjc.6601739
Cancer care in rural areas FREE
R Colomer, J R Germà, R Rosell and J M Borràs
Br J Cancer 90: 1688; advance online publication, March 23, 2004; doi:10.1038/sj.bjc.6601769
Reply: Cancer care in rural areas FREE
N C Campbell, P A Kiehlmann and L Stevenson
Br J Cancer 90: 1689; advance online publication, April 6, 2004; doi:10.1038/sj.bjc.6601770
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
